International Journal of Clinical Oncology

, Volume 23, Issue 3, pp 497–503 | Cite as

Characteristics of MUTYH variants in Japanese colorectal polyposis patients

  • Misato Takao
  • Tatsuro YamaguchiEmail author
  • Hidetaka Eguchi
  • Yuhki Tada
  • Masakazu Kohda
  • Koichi Koizumi
  • Shin-ichiro Horiguchi
  • Yasushi Okazaki
  • Hideyuki Ishida
Original Article



The base excision repair gene MUTYH is the causative gene of colorectal polyposis syndrome, which is an autosomal recessive disorder associated with a high risk of colorectal cancer. Since few studies have investigated the genotype–phenotype association in Japanese patients with MUTYH variants, the aim of this study was to clarify the clinicopathological findings in Japanese patients with MUTYH gene variants who were detected by screening causative genes associated with hereditary colorectal polyposis.


After obtaining informed consent, genetic testing was performed using target enrichment sequencing of 26 genes, including MUTYH.


Of the 31 Japanese patients with suspected hereditary colorectal polyposis, eight MUTYH variants were detected in five patients. MUTYH hotspot variants known for Caucasians, namely p.G396D and p.Y179D, were not among the detected variants.Of five patients, two with biallelic MUTYH variants were diagnosed with MUTYH-associated polyposis, while two others had monoallelic MUTYH variants. One patient had the p.P18L and p.G25D variants on the same allele; however, supportive data for considering these two variants ‘pathogenic’ were lacking.


Two patients with biallelic MUTYH variants and two others with monoallelic MUTYH variants were identified among Japanese colorectal polyposis patients. Hotspot variants of the MUTYH gene for Caucasians were not hotspots for Japanese patients.


MUTYH gene Multiple colorectal tumors Hereditary colorectal tumor 



We thank the patients and their family members for participation in the study.

Author contributions

All authors contributed to this work. MT performed data collection and in silico analysis, and wrote the manuscript; TY performed genetic counseling and wrote the manuscript; HE, YT, MK, YO, and HI performed genetic analysis; KK performed genetic counseling; and SH made histological diagnosis.


This study was supported in part by a Grant-in-aid for the Support Project of the Strategic Research Center in Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan awarded to the Saitama Medical University Research Center for Genomic Medicine (S1311002), a Grant supported by the Program for an Integrated Database of Clinical and Genomic Information from Japan Agency for Medical Research and Development (AMED) and the Office of Metropolitan Hospital Management, Tokyo Metropolitan Government for their financial support.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.


  1. 1.
    Nishisho I, Nakamura Y, Miyoshi Y et al (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665–669CrossRefPubMedGoogle Scholar
  2. 2.
    Powell SM, Petersen GM, Krush AJ et al (1993) Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 329:1982–1987CrossRefPubMedGoogle Scholar
  3. 3.
    Miyoshi Y, Ando H, Nagase H et al (1992) Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci USA 89:4452–4456CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Armstrong JG, Davies DR, Guy SP et al (1997) APC mutations in familial adenomatous polyposis families in the Northwest of England. Hum Mutat 10:376–380CrossRefPubMedGoogle Scholar
  5. 5.
    Giarola M, Stagi L, Presciuttini S et al (1999) Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: evidence for phenotypic differences in cases with and without identified mutation. Hum Mutat 13:116–123CrossRefPubMedGoogle Scholar
  6. 6.
    Nagase H, Miyoshi Y, Horii A et al (1992) Screening for germ-line mutations in familial adenomatous polyposis patients: 61 new patients and a summary of 150 unrelated patients. Hum Mutat 1:467–473CrossRefPubMedGoogle Scholar
  7. 7.
    van der Luijt RB, Khan PM, Vasen HF et al (1997) Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern analysis. Hum Mutat 9:7–16CrossRefPubMedGoogle Scholar
  8. 8.
    Al-Tassan N, Chmiel NH, Maynard J et al (2002) Inherited variants of MYH associated with somatic G:C → T: a mutations in colorectal tumors. Nat Genet 30:227–232CrossRefPubMedGoogle Scholar
  9. 9.
    Sieber OM, Lipton L, Crabtree M et al (2003) Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 27:791–799CrossRefGoogle Scholar
  10. 10.
    Theodoratou E, Campbell H, Tenesa A et al (2010) A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer 103:1875–1884CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Wang L, Baudhuin LM, Boardman LA et al (2004) MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology 127:9–16CrossRefPubMedGoogle Scholar
  12. 12.
    Lejeune S, Guillemot F, Triboulet JP et al (2006) Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis. Hum Mutat 27:1064CrossRefPubMedGoogle Scholar
  13. 13.
    Shinmura K, Kato H, Goto M et al (2016) Functional evaluation of nine missense-type variants of the human DNA glycosylase enzyme MUTYH in the Japanese population. Hum Mutat 37:350–353CrossRefPubMedGoogle Scholar
  14. 14.
    Taki K, Sato Y, Nomura S et al (2016) Mutation analysis of MUTYH in Japanese colorectal adenomatous polyposis patients. Fam Cancer 15:261–265CrossRefPubMedGoogle Scholar
  15. 15.
    Kohda M, Kumamoto K, Eguchi H et al (2016) Rapid detection of germline mutations for hereditary gastrointestinal polyposis/cancers using HaloPlex target enrichment and high-throughput sequencing technologies. Fam Cancer 15:553–562CrossRefPubMedGoogle Scholar
  16. 16.
    Adzhubei IA, Schmidt S, Peshkin L et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073–1081CrossRefPubMedGoogle Scholar
  18. 18.
    Choi Y, Sims GE, Murphy S et al (2012) Predicting the functional effect of amino acid substitutions and indels. PLoS One 7:e46688. CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Thomas PD, Campbell MJ, Kejariwal A et al (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13:2129–2141CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Salgado D, Desvignes JP, Rai G et al (2016) UMD-predictor: a high-throughput sequencing compliant system for pathogenicity prediction of any human cDNA substitution. Hum Mutat 37:439–446CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Niroula A, Urolagin S, Vihinen M (2015) PON-P2: prediction method for fast and reliable identification of harmful variants. PLoS One 10:e0117380. CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Out AA, Tops CM, Nielsen M et al (2010) Leiden Open Variation Database of the MUTYH gene. Hum Mutat 31:1205–1215CrossRefPubMedGoogle Scholar
  23. 23.
    Lek M, Karczewski KJ, Minikel EV et al (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285–291CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Tao H, Shinmura K, Hanaoka T et al (2004) A novel splice-site variant of the base excision repair gene MYH is associated with production of an aberrant mRNA transcript encoding a truncated MYH protein not localized in the nucleus. Carcinogenesis 25:1859–1866CrossRefPubMedGoogle Scholar
  25. 25.
    Yanaru-Fujisawa R, Matsumoto T, Ushijima Y et al (2008) Genomic and functional analyses of MUTYH in Japanese patients with adenomatous polyposis. Clin Genet 73:545–553CrossRefPubMedGoogle Scholar
  26. 26.
    Sampson JR, Dolwani S, Jones S et al (2003) Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 362:39–41CrossRefPubMedGoogle Scholar
  27. 27.
    Rosner G, Bercovich D, Daniel Y et al (2015) Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews. Fam Cancer 14:427–436CrossRefPubMedGoogle Scholar
  28. 28.
    Cleary SP, Cotterchio M, Jenkins MA et al (2009) Germline MutY human homologue mutations and colorectal cancer: a multisite case–control study. Gastroenterology 136:1251–1260CrossRefPubMedGoogle Scholar
  29. 29.
    Jones N, Vogt S, Nielsen M et al (2009) Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. Gastroenterology 137:489–494CrossRefPubMedGoogle Scholar
  30. 30.
    Win AK, Dowty JG, Cleary SP et al (2014) Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology 146:1208–1211CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2018

Authors and Affiliations

  • Misato Takao
    • 1
    • 2
  • Tatsuro Yamaguchi
    • 1
    • 3
    • 4
    Email author
  • Hidetaka Eguchi
    • 5
    • 8
  • Yuhki Tada
    • 5
    • 9
  • Masakazu Kohda
    • 5
    • 8
  • Koichi Koizumi
    • 6
  • Shin-ichiro Horiguchi
    • 7
  • Yasushi Okazaki
    • 5
    • 8
  • Hideyuki Ishida
    • 2
  1. 1.Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases CenterKomagome HospitalTokyoJapan
  2. 2.Department of Digestive Tract and General Surgery, Saitama Medical CenterSaitama Medical UniversitySaitamaJapan
  3. 3.Department of Clinical Genetics, Tokyo Metropolitan Cancer and Infectious Diseases CenterKomagome HospitalTokyoJapan
  4. 4.Hereditary Tumor Research Project, Tokyo Metropolitan Cancer and Infectious Diseases CenterKomagome HospitalTokyoJapan
  5. 5.Division of Translational Research, Research Center for Genomic MedicineSaitama Medical UniversityHidakaJapan
  6. 6.Department of Gastroenterology, Tokyo Metropolitan Cancer and Infectious Diseases CenterKomagome HospitalTokyoJapan
  7. 7.Department of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases CenterKomagome HospitalTokyoJapan
  8. 8.Diagnosis and Therapeutics of Intractable Diseases and Intractable Disease Research CenterJuntendo University Graduate School of MedicineTokyoJapan
  9. 9.Technology and Development Team for Mammalian Genome DynamicsRIKEN BioResource CenterTsukubaJapan

Personalised recommendations